-
1
-
-
0003438833
-
-
Geneva: World Health Organization, 102
-
The World Health Report 1999. Geneva: World Health Organization, 1999;102.
-
(1999)
The World Health Report 1999
-
-
-
2
-
-
0026567697
-
Epidemiology of stroke
-
Bonita R. Epidemiology of stroke. Lancet 339 (1992) 342-344
-
(1992)
Lancet
, vol.339
, pp. 342-344
-
-
Bonita, R.1
-
3
-
-
0033598606
-
Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations
-
Hankey G., and Warlow C.P. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 354 (1999) 1457-1463
-
(1999)
Lancet
, vol.354
, pp. 1457-1463
-
-
Hankey, G.1
Warlow, C.P.2
-
4
-
-
0032564144
-
Epidemiology of stroke
-
Warlow C. Epidemiology of stroke. Lancet 352 Suppl. 3 (1998) 1-4
-
(1998)
Lancet
, vol.352
, Issue.SUPPL. 3
, pp. 1-4
-
-
Warlow, C.1
-
5
-
-
0025125821
-
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage
-
Bamford J., Sandercock P., Dennis M., et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 53 (1990) 16-22
-
(1990)
J Neurol Neurosurg Psychiatry
, vol.53
, pp. 16-22
-
-
Bamford, J.1
Sandercock, P.2
Dennis, M.3
-
6
-
-
0028783948
-
Tissue plasminogen activator for acute ischemic stroke
-
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
-
(1995)
N Engl J Med
, vol.333
, pp. 1581-1587
-
-
-
7
-
-
0029846911
-
Report of the quality standards subcommittee of the American Academy of Neurology
-
Practice advisory: thrombolytic therapy for acute ischemic stroke - summary statement. Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 47 (1996) 835-839
-
(1996)
Neurology
, vol.47
, pp. 835-839
-
-
-
8
-
-
33846946825
-
Hyperacute thrombolysis with IV rt-PA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing country
-
Padma M.V., Singh M.B., Bhatia R., et al. Hyperacute thrombolysis with IV rt-PA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing country. Neurol India 55 (2007) 46-49
-
(2007)
Neurol India
, vol.55
, pp. 46-49
-
-
Padma, M.V.1
Singh, M.B.2
Bhatia, R.3
-
9
-
-
0027514354
-
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment
-
Adams Jr. H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 (1993) 35-41
-
(1993)
Stroke
, vol.24
, pp. 35-41
-
-
Adams Jr., H.P.1
Bendixen, B.H.2
Kappelle, L.J.3
-
10
-
-
29144435915
-
Increasing use of intravenous rt-PA does not affect safety in acute stroke
-
Pfefferkorn T., Liebetrau M., Müllner A., et al. Increasing use of intravenous rt-PA does not affect safety in acute stroke. J Neurol 252 (2005) 1500-1503
-
(2005)
J Neurol
, vol.252
, pp. 1500-1503
-
-
Pfefferkorn, T.1
Liebetrau, M.2
Müllner, A.3
-
11
-
-
33846347159
-
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
-
Wahlgren N., Ahmed N., Dávalos A., et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369 (2007) 275-282
-
(2007)
Lancet
, vol.369
, pp. 275-282
-
-
Wahlgren, N.1
Ahmed, N.2
Dávalos, A.3
-
12
-
-
41849116326
-
Thrombolysis in acute ischaemic stroke within 3 hours of symptom onset: a report of the first 100 cases
-
Litwin T., Kobayashi A., Skowrońska M., et al. Thrombolysis in acute ischaemic stroke within 3 hours of symptom onset: a report of the first 100 cases. Neurol Neurochir Pol 42 (2008) 1-5
-
(2008)
Neurol Neurochir Pol
, vol.42
, pp. 1-5
-
-
Litwin, T.1
Kobayashi, A.2
Skowrońska, M.3
-
13
-
-
34347402604
-
Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit
-
Yoneda Y., Yamanot S., Hera Y., et al. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit. Clin Neurol Neurosurg 109 (2007) 567-570
-
(2007)
Clin Neurol Neurosurg
, vol.109
, pp. 567-570
-
-
Yoneda, Y.1
Yamanot, S.2
Hera, Y.3
-
14
-
-
0031782896
-
Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors
-
Trouillas P., Nighoghossian N., Derex L., et al. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke 29 (1998) 2529-2540
-
(1998)
Stroke
, vol.29
, pp. 2529-2540
-
-
Trouillas, P.1
Nighoghossian, N.2
Derex, L.3
-
15
-
-
0034161354
-
Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study
-
Albers G.W., Bates V.E., Clark W.M., et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283 (2000) 1145-1150
-
(2000)
JAMA
, vol.283
, pp. 1145-1150
-
-
Albers, G.W.1
Bates, V.E.2
Clark, W.M.3
|